arrow
E

Edwin Zvartau

first pavlov state medical university
H-index:36
Citation Count:6,743
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

Sex differences in beneficial and pathogenic bacteria in People With HIV (PWH) with a history of heavy alcohol drinking

HIV感染者中,有益菌和致病菌的性别差异(该感染者有大量饮酒史)

2025-11-220
OAAI
Orvinol-based opioid receptor antagonist fluorinated at C (20)-pharmacophore
2025-02-010
PRE
Effects of Opioid Withdrawal on Psychobiology in People Living with HIV
2024-01-060
OAAI
C(21)-fluorinated thevinol scaffold for opioid ligands. 21,21,21-Trifluoro-6-O-nororvinols: Design, synthesis and analgesic activity
2023-04-015
PRE
Clonidine lowers interleukin-6 in people with hiv during opioid withdrawal
2021-12-010
PRE
Selectivity of taar1 partial agonist ro5263397 effects on drug- versus non-drug-related behaviors
2021-12-010
PRE
Craving for opioids affects retention in treatment and adherence to antiretrovirals in hiv positive patients with oud treated with naltrexone
2019-12-010
PREAI
Does alcohol use provoke relapse in patients with opioid use disorder stabilized on naltrexone?
2019-12-010
PREAI
The Action of TAAR1 Agonist RO5263397 on Executive Functions in Rats
2019-11-1615
PREAI
Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial
2019-04-0115
OAAI
Opening up new horizons for psychiatric genetics in the Russian Federation: moving toward a national consortium
2019-01-2115
OAAI
Fatal overdose in recently detoxified Russian HIV-positive persons with opioid use disorder: The role of naltrexone in prevention
2019-01-010
PREAI
PHARMACOECONOMICS OF DIFFERENT TREATMENTS FOR STEROID-REFRACTORY GRAFT VERSUS HOST REACTION: ANALYSIS OF TREATMENT RESULTS IN A SINGLE-CENTER STUDY
2018-10-010
OAAI
Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction
2018-04-1230
PREAI
Role of dopamine and opioid gene polymorphisms in efficacy of naltrexone and guanfacine combination for relapse prevention among opioid addicts
2017-10-010
PREAI
mGlu1 receptor as a drug target for treatment of substance use disorders: time to gather stones together?
2017-03-115
PREAI
Psychiatric symptoms, quality of life, and HIV status among people using opioids in Saint Petersburg, Russia
2017-03-016
OAAI
The role of genetic polymorphisms on patient response to opioid use disorder therapy with naltrexone and guanfacine
2017-02-010
PREAI
Morphine-induced Straub tail reaction in mice treated with serotonergic compounds
2016-11-0112
PREAI
Antagonist Models for Relapse Prevention and Reducing HIV Risk
2016-02-271
PREAI